Summary
Recent data from the US show that since 1990 the number of paediatric patients with AIDS is decreasing while the number of patients with AIDS over age 50 years is increasing. To date, little attention has been given to understanding AIDS risk-taking behaviours, clinical presentations, and therapeutic needs of middle-aged and older HIV-infected individuals.
Older HIV-infected individuals deteriorate more rapidly than younger patients due to an accelerated loss of CD4+ helper T cells. Despite recognised age-related physiological differences between voung and elderly individuals, scant information about drug optimisation for the treatment of AIDS in older individuals is available. More data need to be collected about this group of AIDS patients, and appropriate treatment strategies designed for their special needs.
Similar content being viewed by others
References
Alder WH, Nagel JE. Clinical immunology and aging. In Hazzard, Bierman, Blass et al. (Eds.) Principles of Geriatric Medicine and Gerontology, 3rd ed., pp. 61–75, McGraw-Hill, New York, 1994
Anderson K, Gorgone B, Marlink R, et al. Transfusion acquired HIV infection among immunocompromised persons. Annals of Internal Medicine 105: 519–527, 1986
Arendt G, Hefter H, Nelles HW, et al. Age-dependent decline in cognitive information processing of HIV-positive individuals detected by event-related potential recordings. Journal of the Neurological Sciences 115: 223–229, 1993
Bacchetti P, Moss AR. Incubation period of AIDS in San Francisco. Nature 338: 251–253, 1989
Bachetti P, Osmond D, Chaisson RE, et al. Survival Patterns of the first 500 patients with AIDS in San Francisco. Journal of Infectious Diseases 157: 1044–1047, 1988
Benjamin AE. Long-term care and AIDS: Perspectives from experience with the elderly. Milbank Quarterly 66: 415–443, 1988
Berglund O, Beckman S, Grillner L, et al. HIV transmission by blood transfusions in Stockholm 1979–1985. AIDS 2: 51–54, 1988
Blaxhult A, Granath F, Lidman K, et al. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 4: 125–129, 1990
Cairoli S, Brustia R, Bono G, et al. AIDS in presenile age: frequency of AIDS-dementia symptoms. [Abstract] International Conference on AIDS 1991 7: 184, 1991
Catania JA, Turner H, Kegeles SM, et al. HIV transmission risks of older heterosexuals and gays. In Riley et al. (Eds.) AIDS in an aging society: what we need to know, pp. 77–95, Springer, New York, 1989
Centers for Disease Control. Update: acquired immunodeficiency syndrome — United States, 1981–1990. Morbidity and Mortality Weekly Report 40: 358–369, 1991
Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1992. Morbidity and Mortality Weekly Report 41: 1–12, 1993
Chesney MA, Miller HG, Piliavin JA, et al. AIDS and the blood supply. In Miller, et al. (Eds.) AIDS the second decade, pp. 289–358, National Academy Press, Washington, D.C., 1990
Couch RB, Kasel JA, Glezen WP, et al. Influenza: its control in persons and populations. Journal of Infectious Diseases 153: 431–440, 1986
D’Amelio R, Matricardi PM, Nisini R, et al. Prevalence of HBV markers in the Italian Armed Forces and HBV vaccination. Military Medicine 154: 589–592, 1989
Eyster ME, Gail MH, Ballard JO, et al. Natural history of human immunodeficiency virus infections in hemophiliacs: Effects of T-cell subsets, platelet counts and age. Annals of Internal Medicine 107: 1–6, 1987
Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. European Journal of Immunology 23: 2375–2378, 1993
Ferro S, Salit IE. HIV infection in patients over 55 years of age. Journal of Acquired Immune Deficiency Syndromes 5: 348–355, 1992
Friedman BA, Burns TL, Schork MA. A study of national trends in transfusion practice, University of Michigan, Ann Arbor, Michigan, 1980
Finland M, Barnes MW. Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935–1972. Journal of Infectious Diseases 136: 400–415, 1977
Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. New England Journal of Medicine 321: 1141–1148, 1989
Hirokawa K, Albright JW, Makinodan T. Restoration of impaired immune function in aging animals II. Effect of syngeneic thymus and bone marrow grafts. Clinical Immunology and Immunopathology 5: 371–376, 1976
Hirsch MS, D’Aquila RT. Therapy for human immunodeficiency virus infection. New England Journal of Medicine 328: 1686–1695, 1993
Kendall MD. Age and seasonal changes in the thymus. In Kendall (Ed.) The thymus gland, pp. 21–33, Academic, London, 1981
Kendig NE, Chrest FJ, Nagel JE, et al. Age-related changes in the immune function of HIV-1 seropositive adults. Aging Immunology and Infectious Disease 3: 67–80, 1991
Klein J. Systemic and regional immune responses. In Klein (Ed.) Immunology, pp. 369–385, Blackwell, Boston, 1990
Levy RM, Bredesen DE, Rosenblum ML, et al. Central nervous system disorders in AIDS. Immunology Series 44: 371–401, 1989
Lindeman RD. Changes in renal function with aging. Implications for treatment. Drugs & Aging 2: 423–431, 1992
Medley GF, Anderson RM, Cox DR, et al. Incubation period of AIDS in patients infected via blood transfusion. Nature 328: 719–721, 1987
Moss AR, Bachetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three year follow-up of the San Francisco General Hospital Cohort. British Medical Journal 296: 745–750, 1988
Padian N, Marquis L, Francis DP, et al. Male-to-female transmission of human immunodeficiency virus. Journal of the American Medical Association 258: 788–789, 1987
Peterman TA, Stoneburner RL, Allen JR, et al. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. Journal of the American Medical Association 259: 55–58, 1988
Phillips AN, Lee CA, Elford J, et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. Journal of Acquired Immune Deficiency Syndromes 4: 970–975, 1991
Rajczy K, Vargha P, Lengyel E, et al. Age dependency of immune response to tetanus toxoid. In Hofecker (Ed.) The Theoretical Basis of Aging Research, pp. 209–216, Vienna: Facultas Verlag, Vienna, 1990
Riley MW, Ory MG, Zablotsky D. AIDS in an aging society: what we need to know, Springer, New York, 1989
Ritschel WA. Identification of populations at risk in drug testing and therapy: application to elderly patients. European Journal of Drug Metabolism and Pharmacokinetics 18: 101–111, 1993
Rothenberg R, Woelfel M, Stoneburner R, et al. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. New England Journal of Medicine 317: 1297–1302, 1987
Sauvageon-Martre H, Bannie F, Tabah I, et al. Pharmacokinetics of zidovudine in AIDS patients: influence of age and hepatic disorders. Abstract. International Conference on AIDS 5: 275, 1989
Scordamaglia A, Ciprandi G, Indiveri F, et al. The effect of aging on host defences. Implications for therapy. Drugs & Aging 1: 303–316, 1991
Ship JA, Wolff A, Selik RM. Epidemiology of acquired immune deficiency syndrome in persons aged 50 years and older. Journal of Acquired Immune Deficiency Syndromes 4: 84–88, 1991
Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Annals of Neurology 14: 403–418, 1983
Stall R, Catania J. AIDS risk behaviours among late middle-aged and elderly Americans: the National AIDS behavioural surveys. Archives of Internal Medicine 154: 57–63, 1994
Wilde MI, Langtry HD. Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 46: 515–578, 1993
Woodhouse K, Wynne HA. Age-related changes in hepatic function. Implications for drug therapy. Drugs & Aging 2: 243–255, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adler, W.H., Nagel, J.E. Acquired Immunodeficiency Syndrome in the Elderly. Drugs & Aging 4, 410–416 (1994). https://doi.org/10.2165/00002512-199404050-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199404050-00006